Hologic (HOLX) Akcija Kursas
Hologic Kursas
Per pastaruosius 19 metus Hologic pajamos augo 12,2 % kasmet ir pasiekė 4,10 mlrd. USD. Pelnas akcijai augo 12,8 % per metus per pastaruosius 19 metus. Hologic grynoji marža 13,8 % yra sumažėjo palyginti su 33,2 % prieš kelerius metus. Hologic 12 mėn. konsensuso tikslinė kaina yra 77,52 USD, apie virš kursą 2,0 %. Iš 23 analitikų 0 rekomenduoja pirkti — bendras konsensusas yra Laikyti.
Hologic akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Hologic akcija ir akcijų analizė
Dažnai užduodami klausimai apie Hologic akciją
The main competitors of Hologic Inc in the market include companies like Abbott Laboratories, Thermo Fisher Scientific, and Becton, Dickinson and Company.
The business model of Hologic Inc revolves around providing innovative diagnostic solutions, primarily focused on women's healthcare. Hologic develops and markets a wide range of medical devices and instruments, including imaging systems, surgical products, and molecular diagnostic assays. The company's products are designed to enable healthcare professionals to effectively screen, diagnose, and treat various conditions and diseases. Hologic is renowned for its advanced technologies in breast health, gynecology, and skeletal health, offering solutions that empower early detection and intervention. By constantly pushing the boundaries of medical technology, Hologic Inc remains committed to improving healthcare outcomes for women around the world.
Hologic Inc is primarily active in the healthcare industry, specifically in the field of diagnostic products and medical devices. With a focus on improving women's health, Hologic Inc develops and manufactures a wide range of innovative solutions. Their portfolio includes advanced imaging systems, molecular diagnostic assays, surgical instruments, and women's health screening tests. As a prominent player in the healthcare sector, Hologic Inc constantly strives to provide cutting-edge technologies and solutions to address various medical challenges.
Hologic Inc is a leading global healthcare and diagnostics company. Established in 1985, Hologic has excelled in providing innovative solutions for women's health, with a focus on early detection and treatment of breast and cervical cancers. The company's dedication to research and development has resulted in breakthrough technologies, including the introduction of the first 3D mammography system. Hologic has expanded its portfolio to include diagnostics, surgical and skeletal health, and GYN surgical products. With a strong commitment to advancing healthcare, Hologic Inc continues to make significant contributions to improving patient outcomes and quality of life.
Hologic Inc, a leading healthcare company, has achieved several significant milestones. In recent years, the company has made notable advancements in breast health solutions. They introduced the world's first 3D mammography system, which revolutionized breast cancer detection by providing clearer and more accurate images. Hologic Inc also developed the Genius™ 3D Mammography™ exam, proven to detect breast cancer at an earlier stage compared to 2D mammography alone. Furthermore, the company expanded its portfolio by acquiring Gen-Probe, a molecular diagnostics company, allowing Hologic Inc to offer a comprehensive range of diagnostic solutions. These milestones highlight Hologic Inc's commitment to innovation and improving women's healthcare outcomes.
Hologic Inc is primarily present in various countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered. Additionally, Hologic Inc operates in Europe, including countries like Germany, France, Italy, and the United Kingdom. It also has a presence in Asia, particularly in countries such as China and Japan. Furthermore, Hologic Inc serves customers in Canada and Latin America, with a focus on countries like Mexico and Brazil. Overall, Hologic Inc has a global reach and aims to provide its products and services to diverse markets internationally.
Hologic Inc represents values of innovation, commitment to quality, and patient-centric approach. The corporate philosophy of Hologic Inc revolves around developing cutting-edge medical technologies to improve women's health outcomes. With a focus on providing accurate and reliable diagnostic solutions, Hologic Inc strives to empower healthcare professionals and patients alike. The company's dedication to research and development, evidence-based practices, and collaboration with healthcare experts reinforces its commitment to advancing healthcare for women globally. Hologic Inc's mission is to make a difference in people's lives through advanced healthcare solutions, making them a trusted and reliable leader in the industry.
Analitikai šiuo metu nustato vidutinę Hologic akcijos tikslinę kainą 76,66 USD (mediana: 77,52 USD), t. y. +0,9 % palyginti su paskutine kaina. Konsensusas pagrįstas 23 analitikų reitingais.
23 analitikai šiuo metu vertina Hologic akciją: 0 rekomenduoja pirkti, 20 laikyti ir 3 parduoti. 2026 m. analitikai tikisi, kad Hologic gaus 4,24 mlrd. USD pajamų ir 4,49 USD pelno akcijai.
Pagal dabartinį kursą Hologic akcija kainuoja 67,67 EUR (76,01 USD).
Hologic akcija (HOLX) kotiruojama 9 biržose, įskaitant: NASDAQ (HOLX), London (0J5Q.L), SIX (Zürich) (HO1.SW), XETRA (HO1.DE), Frankfurt (HO1.F), München (HO1.MU), Düsseldorf (HO1.DU), Wien (HOLX.VI).
Hologic Inc is an international leading provider of medical technology products and solutions. The company, headquartered in Marlborough, Massachusetts, operates globally and is divided into four business segments: Diagnostics, Gynecology, Skeletal Health, and Aesthetics.
tikėtina pelnas Hologic yra 4,24 mlrd. USD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas Hologic yra 1,01 mlrd. USD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Hologic šiuo metu yra 16,93. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Hologic akcijos vertę.
Kainų ir pardavimų santykis (KUV) Hologic šiuo metu yra 4,05. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Hologic akcijos įvertinimo metrika.
Eulerpool kokybės balas Hologic yra 1/10.
Hologic ISIN yra US4364401012. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Hologic WKN yra 879100. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Hologic prekybos žymė yra HOLX. Ši biržos žymė naudojama Hologic akcijoms prekiauti biržoje.
Hologic akcija
Hologic Pagrindiniai konkurentai
Hologic Biržos simbolis
Hologic FIGI
Visos Hologic pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Hologic akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Hologic. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: